Shares of PRA Health Sciences Inc. (NASDAQ:PRAH) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $51.99 and last traded at $51.85, with a volume of 832,405 shares trading hands. The stock had previously closed at $49.25.

Several analysts recently issued reports on PRAH shares. Credit Suisse Group AG started coverage on shares of PRA Health Sciences in a research report on Monday, June 20th. They issued a “neutral” rating and a $43.00 price target for the company. KeyCorp reissued a “hold” rating on shares of PRA Health Sciences in a research report on Sunday, May 22nd. Jefferies Group reissued a “buy” rating and issued a $57.00 price target on shares of PRA Health Sciences in a research report on Friday, July 29th. Zacks Investment Research downgraded shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, First Analysis started coverage on shares of PRA Health Sciences in a research report on Monday, June 20th. They issued an “equal weight” rating and a $47.00 price target for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $48.94.

The firm has a 50-day moving average price of $44.51 and a 200 day moving average price of $44.37. The company has a market cap of $3.18 billion and a P/E ratio of 44.82.

PRA Health Sciences (NASDAQ:PRAH) last announced its earnings results on Thursday, July 28th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. During the same quarter in the prior year, the company earned $0.47 EPS. The business had revenue of $394.20 million for the quarter, compared to the consensus estimate of $381.25 million. PRA Health Sciences’s revenue was up 16.0% compared to the same quarter last year. On average, analysts predict that PRA Health Sciences Inc. will post $2.46 earnings per share for the current fiscal year.

A hedge fund recently bought a new stake in PRA Health Sciences stock. Cornerstone Capital Management Holdings LLC. bought a new position in shares of PRA Health Sciences Inc. (NASDAQ:PRAH) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,727 shares of the company’s stock, valued at approximately $1,346,000.

PRA Health Sciences, Inc is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.